➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Patent: 7,494,671

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,494,671
Title:Extract of Trapa natans and methods of using the same
Abstract: The present invention provides extracts of Trapa natans L. useful for inhibiting, interfering and/or controlling pathological angiogenesis or neovascularization of tissues. The invention also provides a method to inhibit metastatis of cancer of colon, lung, liver, kidney, breast and/or cervix in a subject, comprising administering an effective amount of an extract of Trapa natans L. to the subject.
Inventor(s): Wong; Kin-Ping (Fresno, CA), Wong; Ming-Chung (Fresno, CA)
Assignee: Wong; Kin-Ping (Fresno, CA)
Application Number:11/123,150
Patent Claims:see list of patent claims

Details for Patent 7,494,671

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Start Trial Wong; Kin-Ping (Fresno, CA) 2022-11-08 RX search
Organon Usa Inc. BCG VACCINE bacillus calmette-guerin substrain tice live antigen INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 103050 1 1989-06-21   Start Trial Wong; Kin-Ping (Fresno, CA) 2022-11-08 search
Chiron PROLEUKIN aldesleukin VIAL 103293 001 1992-05-05   Start Trial Wong; Kin-Ping (Fresno, CA) 2022-11-08 RX search
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20   Start Trial Wong; Kin-Ping (Fresno, CA) 2022-11-08 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.